Aclaris Therapeutics to Participate in Two June Healthcare Conferences
Aclaris Therapeutics to Participate in Two June Healthcare Conferences GlobeNewswire May 28, 2025 WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in June. On Wednesday […]